Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Study

被引:0
作者
Long, Millie D. [1 ]
Kane, Sunanda [2 ]
Beaulieu, Dawn [3 ]
Abraham, Bincy [4 ]
Zhang, Xian [1 ]
Mahadevan, Uma [5 ]
机构
[1] Univ North Carolina, Chapel Hill, NC 27599 USA
[2] Mayo Clin, Rochester, MN USA
[3] Vanderbilt Univ, Nashville, TN USA
[4] Houston Methodist, Houston, TX USA
[5] Univ Calif San Francisco, San Francisco, CA USA
关键词
inflammatory bowel disease; Crohn's disease; ulcerative colitis; pregnancy; biosimilar;
D O I
10.14309/ctg.0000000000000795
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION: We aimed to compare pregnancy outcomes of women with inflammatory bowel disease using biosimilar vs originator infliximab (IFX). METHODS: In a prospective cohort of pregnant women with inflammatory bowel disease, we collected characteristics, medications, pregnancy outcomes, and developmental milestones. We compared outcomes by IFX biosimilar or originator use via bivariate statistics. RESULTS: A total of 100 pregnant women on originator IFX and 20 on biosimilar IFX were included. There were no differences in pregnancy complications between groups (48% vs 35%, P = 0.29). Infant developmental milestones were comparable at 12 months. DISCUSSION: Biosimilar IFX is not associated with adverse pregnancy or infant outcomes.
引用
收藏
页数:4
相关论文
共 16 条
[1]   Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines [J].
Beaulieu, Dawn B. ;
Ananthakrishnan, Ashwin N. ;
Martin, Christopher ;
Cohen, Russell D. ;
Kane, Sunanda V. ;
Mahadevan, Uma .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (01) :99-105
[2]   Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors [J].
Chicharo, Ana Teodosio ;
Lopes, Ana R. ;
Barreira, Sofia ;
Pinto, Luisa ;
Cruz-Machado, Ana R. ;
Capela, Susana .
RHEUMATOLOGY ADVANCES IN PRACTICE, 2024, 8 (02)
[3]   Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus [J].
D'Amico, Ferdinando ;
Solitano, Virginia ;
Magro, Fernando ;
Olivera, Pablo A. ;
Halfvarson, Jonas ;
Rubin, David ;
Dignass, Axel ;
Al Awadhi, Sameer ;
Kobayashi, Taku ;
Queiroz, Natalia Sousa Freitas ;
Calvo, Marta ;
Kotze, Paulo Gustavo ;
Ghosh, Subrata ;
Peyrin-Biroulet, Laurent ;
Danese, Silvio .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
[4]   The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects [J].
Declerck, Paul ;
Danesi, Romano ;
Petersel, Danielle ;
Jacobs, Ira .
DRUGS, 2017, 77 (06) :671-677
[5]   Addressing pregnancy-related concerns in women with inflammatory bowel disease: Insights from the patient's perspective [J].
Flanagan, Emma K. ;
Richmond, Jacqui ;
Thompson, Alexander J. ;
Desmond, Paul, V ;
Bell, Sally J. .
JGH OPEN, 2021, 5 (01) :28-33
[6]   Biologics and pregnancy: a clinician's guide to the management of IBD in pregnant women [J].
Guerrero Vinsard, Daniela ;
Kane, Sunanda V. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (06) :633-641
[7]  
HARVEY RF, 1980, LANCET, V1, P514
[8]   Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection [J].
Julsgaard, Mette ;
Christensen, Lisbet A. ;
Gibson, Peter R. ;
Gearry, Richard B. ;
Fallingborg, Jan ;
Hvas, Christian L. ;
Bibby, Bo M. ;
Uldbjerg, Niels ;
Connell, William R. ;
Rosella, Ourania ;
Grosen, Anne ;
Brown, Steven J. ;
Kjeldsen, Jens ;
Wildt, Signe ;
Svenningsen, Lise ;
Sparrow, Miles P. ;
Walsh, Alissa ;
Connor, Susan J. ;
Radford-Smith, Graham ;
Lawrance, Ian C. ;
Andrews, Jane M. ;
Ellard, Kathrine ;
Bell, Sally J. .
GASTROENTEROLOGY, 2016, 151 (01) :110-119
[9]   Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy [J].
Leone, Gian Marco ;
Mangano, Katia ;
Petralia, Maria Cristina ;
Nicoletti, Ferdinando ;
Fagone, Paolo .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
[10]   Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease [J].
Mahadevan, Uma ;
Long, Millie D. ;
Kane, Sunanda, V ;
Roy, Abhik ;
Dubinsky, Marla C. ;
Sands, Bruce E. ;
Cohen, Russell D. ;
Chambers, Christina D. ;
Sandborn, William J. .
GASTROENTEROLOGY, 2021, 160 (04) :1131-1139